Outcomes of retrograde intrarenal surgery compared with ultra-mini percutaneous nephrolithotomy in the management of renal calculi

• Published in: Central European journal of urology Vol. 72; no. 2; pp. 169 - 173
• Main Authors: Pai, Aakash, Wai, Htut Aung, Ali, Miriam, Theaker, Michael, Watson, Graham, Mackie, Simon
• Format: Journal Article
• Language: English
• Published: Poland Polish Urological Association 01.01.2019
• Subjects: Feasibility studies; Kidney stones; Lithotripsy; Original Paper; Patient satisfaction; Statistical analysis; Surgery; Systematic review; renal calculi; flexible ureteroscopy; ultra-mini percutaneous nephrolithotomy
• ISSN: 2080-4806; 2080-4873; 2080-4873
• DOI: 10.5173/ceju.2019.1928

To evaluate the outcomes of retrograde intrarenal surgery (RIRS) and ultra-mini percutaneous nephrolithotomy (umPCNL) in the management of renal calculi. Between March 2015 and January 2018, a total of 44 patients were treated with umPCNL. The outcomes of these patients were compared with 75 patients who underwent RIRS for renal calculi during the same time period. Median stone size was 9 mm in the umPCNL group and 7 mm in the RIRS group. Stone-free rates after a single procedure were achieved in 85% of patients for the RIRS group and 98% for the umPCNL group. 16% of RIRS patients were left with a ureteric stent, whilst 7% of patients (n = 5) needed a second RIRS. One patient in the umPCNL group was left with a percutaneous nephrostomy; all other patients were left totally tubeless. The mean operative time was 66 minutes in the RIRS group and 55 minutes in the umPCNL group (p = 0.04). The minor complication rates for the RIRS and umPCNL groups were 17% and 15%, respectively. One patient in the RIRS group required postoperative nephrostomy insertion; there were no major complications in the umPCNL group. The median length of stay was 0 days in the RIRS group and 1 day in the umPCNL group. The overall study showed that umPCNL has low complication rates and good stone-free rates, with a lower requirement for ancilliary procedures. UmPCNL is an acceptable alternative in selected patients with small- to moderate-sized renal calculi.